Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002007919-25-000070
Filing Date
2025-05-29
Accepted
2025-05-29 16:32:20
Documents
1
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748550731.html 4  
1 FORM 4 wk-form4_1748550731.xml 4 3909
  Complete submission text file 0002007919-25-000070.txt   5479
Mailing Address C/O WEBMD HEALTH CORP. 111 EIGHTH AVENUE NEW YORK NY 10011
Business Address
Vuori Kristiina MD (Reporting) CIK: 0001612627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 251003978

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)